The validity of each new cardiac output (CO) monitor should be established before implementation in clinical practice. For this purpose, method comparison studies investigate the accuracy and precision against a reference technique. With the emergence of continuous CO monitors, the ability to detect changes in CO, in addition to its absolute value, has gained interest. Therefore, method comparison studies increasingly include assessment of trending ability in the data analysis. A number of methodological challenges arise in method comparison research with respect to the application of Bland-Altman and trending analysis. Failure to face these methodological challenges will lead to misinterpretation and erroneous conclusions. We therefore review the basic principles and pitfalls of Bland-Altman analysis in method comparison studies concerning new CO monitors. In addition, the concept of clinical concordance is introduced to evaluate trending ability from a clinical perspective. The primary scope of this review is to provide a complete overview of the pitfalls in CO method comparison research, whereas other publications focused on a single aspect of the study design or data analysis. This leads to a stepwise approach and checklist for a complete data analysis and data representation.
limitations. 11 As an alternative, the concept of 'clinical concordance' and a corresponding error grid method for evaluation of trending ability from a clinical perspective is introduced. Finally, the methodological issues are summarized, resulting in a stepwise approach and checklist for CO method comparison research. The use of this checklist could lead to a more complete and homogeneous presentation of data, which may facilitate systematic reviews and meta-analyses in the future.
Bland-Altman analysis: concept
Each new CO monitor should be evaluated for its accuracy and precision; accuracy refers to the ability to measure CO close to its true value, whereas precision refers to the spread of repeated measurements (Fig. 1) . Measurement of the 'true' CO is extremely difficult in clinical practice, and reference techniques can provide only an approximation. 1 2 This problem can be handled in part using Bland-Altman analysis. [12] [13] [14] This method evaluates agreement between two measurement techniques, rather than validating the experimental technique against a perfect reference. As a result, only conclusions about interchangeability between the experimental and reference technique can be drawn. Bland-Altman analysis determines the bias, or mean difference between the experimental and reference technique, as a measure of accuracy. [12] [13] [14] As a measure of precision, the 95% limits of agreement (LOA) are used ( determined as:
LOA ¼ ðbiasÞ ± t α;nÀ1 Ã ðSDÞ in which  is the standard deviation of the differences, n the sample size, and t α,n−1 the t-value corresponding to the degrees of freedom (n−1) and a type I error (α) of 0.05. The LOA therefore represent the limits enclosing 95% of the differences. The bias and LOA can be depicted in a Bland-Altman plot (Fig. 1 ). The mean error or percentage error is calculated as follows:
Mean error ð%Þ ¼ 100% Ã t α;nÀ1 Ã ðSDÞ ðmean COÞ Consequently, the mean error is a measure of interchangeability relative to the underlying CO and therefore a more appropriate parameter to compare the results from different studies. For calculation of the LOA and mean error, a t-value of 1.96 is often used. Strictly speaking, this value holds true only in infinitely large sample sizes. It is advisable to use correct t-values in small studies (e.g. <20 subjects), as a value of 1.96 will underestimate the real LOA and mean error.
Pitfalls in the application of Bland-Altman analysis
Bland-Altman analysis has a number of important pitfalls, which are discussed in the next sections, each followed by a recommendation. These recommendations are summarized in a checklist (Table 1) .
Normal distribution
The differences between the experimental and reference technique should be normally distributed. Usually, this will be the case, even if the individual CO measurements with the experimental or reference technique do not follow a normal distribution. 14 If not, a straightforward non-parametric approach is available. 14 15 Normal quantile-quantile (QQ) plots or histograms of the differences provide a visual check of normality. 16 In addition, the Kolmogorov-Smirnov or Shapiro-Wilk test can be applied. Nonetheless, small studies may pass these tests because of insufficient statistical power to demonstrate non-normality. In contrast, large studies tend to be tested non-normal even if the deviation from a normal distribution is small. 16 Recommendation Check the differences between the experimental and reference technique for normality by combining a visual check and statistical test.
Proportionality
The bias and LOA are meaningful estimates only if they are uniform over the range of measurements. 14 If the difference between the techniques increases with an increase in CO, the bias will be overestimated in the low-CO range and underestimated in the high-CO range. This effect is called proportional bias and can be quantified by plotting a regression line in the Bland-Altman plot. If the slope of this line differs significantly from zero, proportional bias is present. 14 17 Nonetheless, in small studies, proportional bias cannot be ruled out because these studies may lack the statistical power to demonstrate this significant difference. Regression analysis should therefore be accompanied of the data or regression analysis can be applied to prevent under-and overestimation in specific measurement ranges; 14 17 however, this limits the interpretation of the study results.
If the bias or LOA are uniform over the range of measurements, the difference between two systems is relatively larger in the lower range in comparison with the higher range. A uniform bias of 0.6 litre min 
Paired measurements
Many studies use multiple measurements in the same subject. Bland-Altman analysis without correction for paired measurements may underestimate the  of the differences, leading to falsely narrow LOA and confidence intervals (CIs). 5 6 12 14 As illustrated by Hamilton and Lewis, 5 this effect increases with a small number of subjects, large number of measurements per subject, and little within-subject variance in comparison to betweensubject variance. This emphasizes the need for correction for paired measurements in studies investigating continuous CO monitoring devices in the absence of major haemodynamic changes. Consecutive measurements will tend to correlate, reducing the within-subject variance. In contrast, major haemodynamic changes may increase the within-subject variance to an extent that measurements become independent. 18 We therefore suggest determining the autocorrelation of repeated measurements first. If this autocorrelation is not negligible, a correction for the use of paired measurements should be applied. Two methods are available for this purpose. 6 14 Bland and Altman 14 provide a method to determine the LOA from the within-subject variances of the experimental and reference methods and the variance of the differences between the within-subject means. Alternatively, Myles and Cui 6 use the average of repeated measurements and use a random effects model to correct for the reduction in variation that occurs by using this average. In addition to these statistical approaches, it is advisable to separate consecutive measurements in time, especially in the absence of major haemodynamic fluctuations. In this way, substantial correlation between consecutive measurements can be prevented.
Recommendation
A correction for the use of paired measurements should be applied unless both autocorrelation and clinical circumstances indicate that the measurements are independent. In the timing of consecutive measurements, the measurement protocol should consider the presence or absence of haemodynamic fluctuations.
Confidence intervals
Investigators should not forget to calculate 95% CIs for the bias, LOA and mean error, because they represent an estimation of their 'true' counterparts in a target population. 7 12 At first sight, bias and LOA in a study may seem clinically acceptable. If, however, the corresponding CIs are wide, considerable differences between two systems can still be present in the target population.
To illustrate this, we reconstructed the CIs of the bias, upper and lower LOA, and mean error in a number of studies (Supplementary Appendix A). Considering the CIs in the data analysis would probably lead to different conclusions in some studies.
The CI of the bias should not be confused with the LOA. 19 The CI of the bias indicates the limits for the bias in the target population, whereas the LOA refer to the spread of the differences in a specific study. The CI of the bias is calculated as bias±t α,n−1 * /√n, and decreases with increasing sample size. Being a measure of spread, the LOA do not decrease by increasing the sample size.
Recommendation
The bias, LOA, and mean error should always be accompanied by their 95% CIs. may be acceptable for patients undergoing surgery with major haemodynamic disturbances, but not for patients with heart failure undergoing cardiac surgery. Clinically acceptable boundaries for bias and LOA or mean error should therefore always be defined in advance, depending on the target patients in which the new device is aimed to be used. 3 To a certain extent, the desirable level of agreement can be adjusted if the new device has clear advantages over the reference technique in terms of safety, handling in clinical practice, or costs.
Recommendation Acceptable boundaries for the bias, LOA, and mean error should be defined in advance.
Sample size calculations
The use of predefined criteria for Bland-Altman variables facilitates the decision-making process of accepting or rejecting new CO monitors for clinical use. However, study results may have the tendency to end up close to the predefined criteria, as these criteria reflect the clinical context in which the study has been performed. If the 95% CIs are wide, there is a substantial risk that they include the predefined criteria, which hinders definite conclusions. It is therefore advisable to consider the appropriate sample size in advance. Sample size calculations for BlandAltman analysis can be considered controversial, because the method is not a statistical test. Moreover, the variability of (repeated) measurements with the new technique is unknown. Despite this, we point to a number of methods to estimate the appropriate sample size. First, the use of a desired maximal width for the 95% CIs around the mean error enables sample size calculations. This method was applied in a previous study
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Similar to this approach, the width of the CIs around the upper and lower LOA can be determined in terms of the , as described by Bland. 21 Third, sample sizes can be estimated based on historical data. We realize that these approaches can be debated, and researchers are free to consider their use; however, we advise reflection on this topic in the design phase of method comparison studies in order to reduce the risk of underpowering.
Recommendation
Sample size calculations may be considered to estimate the appropriate number of subjects.
Reference precision
The LOA and mean error are influenced by the precision of the reference technique. 4 22 This is reflected in the formula by
Critchley and Critchley 22 to derive the mean error from the precision of the experimental and reference techniques, or:
The use of imprecise reference techniques will therefore lead to wide LOA and high mean error, independent of the precision of the new device. 8 12 Intermittent thermodilution CO (TDCO) with a pulmonary artery catheter is frequently used as reference technique. In many studies, the precision of TDCO is assumed to be 20%, and experimental precision should not exceed this 20% to be interchangeable with TDCO. Consequently, the mean error should not exceed √(20 2 +20
2 )=28.3%, which is often rounded up to 30%. 22 The strict use of a 30% limit for the mean error will, however, lead to erroneous conclusions if reference precision is significantly smaller or larger than 20%. Precision of TDCO or alternative techniques, such as transpulmonary thermodilution (TPCO), may even be improved to 5%. 1 23-27 Both TDCO and TPCO can therefore be considered valuable as a reference technique, if properly performed. Moreover, this emphasizes the need for evaluation of reference precision in addition to experimental precision. The  of repeated measurements or 'repeatability' can be used for this purpose. 3 8 Repeatability is defined as 2× of repeated measurements ( rep ) divided by CO. 4 The squared values of experimental and reference repeatability can be added up as:
This 'combined repeatability' represents the maximal variation in repeated experimental and reference measurements that could explain the mean error. The mean error should therefore not exceed this value for the techniques to be interchangeable. 3 8 Recommendation The TDCO and TPCO may be precise reference techniques, if properly performed. Both experimental and reference repeatability should be determined for proper interpretation of the LOA and mean error.
Changes in cardiac output and response time
Changes in CO introduce variability in repeated measurements, irrespective of precision (Fig. 2 ). This does not affect the difference between experimental and reference CO if they are observed at exactly the same moment in time (Fig. 2 ). In the case of differences in response time between experimental and reference CO, however, a difference between the techniques will appear. This has important consequences for studies evaluating continuous devices during haemodynamic changes. These devices need time to process changes in the underlying CO, in contrast to intermittent reference techniques without measurement delay. Discrepancy will therefore emerge during haemodynamic changes, which fade out in time. 20 The timing and recording of measurements is therefore important, and postponing measurements during acute haemodynamic changes should be considered. 20 In acute settings, however, observations are directly followed by therapeutic decisions. To be valid in this situation, monitoring systems should display short response times.
Recommendation
The response time of (continuous) monitoring systems should be taken into account, and the method of collecting and recording CO measurements should be defined clearly. If necessary and appropriate, measurements can be postponed.
Trending ability
An increasing number of studies focus on the ability to track changes in CO, in addition to determining its absolute value. 9 10 Evaluation of the trend in CO might be helpful to evaluate the effects of interventions and is intuitive, because CO is continuously changing as a result of a variety of influences, such as respiration, the autonomic nervous system, and changes in metabolic demand. 24 25 28 The absolute value of CO is useful to consider in the diagnostic work-up of critical care patients. A proper evaluation of trending ability requires that changes in CO are induced in a controlled set-up. Moreover, the timing of and recording of measurements should be described clearly. Differences in response time between the experimental and reference method should be taken into account, and reference CO should be precise, as described earlier.
Bland-Altman analysis, polar plot methodology, and four-quadrant concordance
Although Bland-Altman analysis evaluates the accuracy and precision of absolute CO readings, conclusions about trending ability may be drawn intuitively. If absolute CO measurements are precise, trending ability should be adequate, irrespective of accuracy. Accuracy refers to the mean deviation between a new CO monitor and true CO. This deviation will be fixed in highly precise monitors and therefore irrelevant in tracking CO changes. In imprecise monitors, the deviation from the underlying CO is variable, which makes trending impossible. Theoretically, precision can be used to determine which changes in CO will be followed reliably. Precision of ΔCO is defined as √2 times the precision of a single CO measurement. 4 As a result, a CO measurement device with a precision of 10% can reliably detect changes in CO of >14.1% (√2*10). On the contrary, precision of CO measurement needs to be <7.1% (10/√2) to detect a ΔCO of 10% reliably. Two articles by Critchley and colleagues 9 10 review several methods to evaluate trending ability, including four-quadrant (4Q) concordance and polar plot methodology. The 4Q method plots the change in experimental CO (ΔCO exp ) against the change in reference CO (ΔCO ref )
. 9 The percentage of data points in which ΔCO exp and ΔCO ref change in the same direction is called 4Q concordance. This represents a rather crude estimate of trending ability and does not consider the magnitude of ΔCO exp and ΔCO ref .
In contrast, the polar plot approach enables quantitative assessment of trending ability, which is a major advantage. 9 10 Nonetheless, a number of limitations need to be considered. First, interpretation of the polar variables is not straightforward. The translation of angular bias and radial LOA to clinical practice is not intuitive. Second, the criteria for good trending ability were validated, in a limited number of studies, against concordance and the opinion on trending ability by the authors. As a result, conclusions from polar plot analysis will have the tendency to agree with other statistical methods applied in the past, which limits the added value. Third, the criteria were determined with TDCO as the reference technique. In the case of another reference technique with different precision, the criteria should be adjusted. 1 Fourth, both polar plot and 4Q methods use exclusion zones to limit the influence of small changes in CO that may introduce random noise; however, this reduces statistical power and ignores potentially valuable information. The combination of small increases in ΔCO exp (e.g. +1%) with small decreases in ΔCO ref (e.g. −1%) or vice versa may be considered good trending, because these changes are both insignificant and unlikely to trigger therapeutic actions. In 4Q and polar analysis, these data pairs are excluded.
'Clinical concordance'
Alternatively, it is possible to pass a clinical judgment on each individual data pair. 29 An error grid can be created to reflect the therapeutic consequences in specific zones in the concordance plot (Fig. 3) . The following zones can be distinguished. 
Recommendation
The clinical concordance method should be considered as an alternative or addition to 4Q and polar analysis in the evaluation of trending ability.
Discussion
The present review article describes the methodological challenges with the application of Bland-Altman and trending analysis in CO method comparison research. Moreover, the concept of clinical concordance and a corresponding error grid method is introduced to evaluate trending ability from a clinical perspective. Based on the items discussed, a stepwise approach to the design and data analysis of CO method comparison research can be created (Table 1) . This approach may serve as a checklist for new researchers in the field. In addition, it may help clinicians to interpret the results from these studies in their decisions to incorporate new CO monitoring techniques in daily practice. Although this review focuses on Bland-Altman and trending analysis, the data analysis of method comparison studies should not be restricted to these statistical methods. As in any type of research, the data analysis should include a close look at the raw data, considering outliers, haemodynamic circumstances, and patient characteristics. The scatterplot depicting experimental against reference CO should be evaluated, together with the range of CO measurements, effects in regions with high-or low-CO states, and effects in subgroups of patients. This is important because the performance of CO monitors may differ considerably depending on ( patho)physiological 
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2. conditions in the patient. 1 2 Moreover, method comparison research represents only the initial part of the validation process of new CO monitors. 30 Besides technical efficacy, the ultimate goal of any newly developed monitor is to improve patient outcome and to be cost-effective. Method comparison studies should therefore anticipate application in clinical practice. This was an important reason to point to the use of predefined criteria defined within a desired, future clinical context. In addition, clinical concordance was introduced as a clinically intuitive method for trending ability, in which the level of (dis) agreement is translated to therapeutic consequences. Researchers should challenge themselves to embed the clinical context into their studies, both for a better understanding of the results and in order to facilitate the implementation of new technology in daily care.
